The last 18 months have been very tough for the non-life insurance industry and, particularly, for those in the health business. The companies have had to pay claims in excess of Rs 20,000 crore for something — the pandemic — that was not factored in while designing products. Also, the huge claims outgo has resulted in general insurers’ profitability falling sharply, while for the monoline health insurers it caused a solvency scare. Having said that, the pandemic has also resulted in an unprecedented pick-up in demand for health insurance products, making it the dominant business of the non-life insurance industry.